Waratah Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,487
Closed -$122K 223
2022
Q3
$122K Buy
+10,487
New +$150K ﹤0.01% 167
2017
Q3
Sell
-191,817
Closed -$3.87M 180
2017
Q2
$3.87M Buy
191,817
+12,402
+7% +$270K 0.54% 42
2017
Q1
$4.35M Buy
+179,415
New +$4.84M 0.58% 47
2016
Q3
Sell
-217,680
Closed -$4.64M 126
2016
Q2
$4.64M Buy
+217,680
New +$4.1M 0.95% 38
2014
Q4
Sell
-67,700
Closed -$2.2M 87
2014
Q3
$2.2M Buy
67,700
+34,500
+104% +$1.17M 1.58% 23
2014
Q2
$1.16M Sell
33,200
-12,900
-28% -$424K 0.57% 38
2014
Q1
$1.46M Buy
+46,100
New +$1.28M 0.8% 31

Other funds holding PTEN

Waratah Capital Advisors's PTEN Position: Q4 2022 in Review

Waratah Capital Advisors sold out of Patterson-UTI (PTEN) in Q4 2022, closing a stake of 10,487 shares — an estimated $122K sold.

Waratah Capital Advisors first reported a position in PTEN in Q1 2014 and held it in 7 quarters. The position peaked at $4.64M in Q2 2016. 305 funds tracked by Wall St. Rank hold PTEN as of Q4 2022.

  • Waratah Capital Advisors reported no remaining Patterson-UTI position as of Q4 2022 after selling out during the quarter.
  • Waratah Capital Advisors sold 10,487 Patterson-UTI shares in Q4 2022, an estimated $122K.
  • Waratah Capital Advisors first reported a position in Patterson-UTI in Q1 2014 and held it in 7 quarters.
  • Waratah Capital Advisors's Patterson-UTI position peaked at $4.64M in Q2 2016.
  • 305 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2022.

Based on Waratah Capital Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.